Biomarin Pharmaceutical (BMRN) EBITDA (2009 - 2026)
Biomarin Pharmaceutical's EBITDA came in at $208.56 million for Q2 2026, down 29.4% from $295.45 million a year earlier but up 42.8% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported EBITDA of $302.23 million, down 64.8% year-over-year; for FY2025, it was $489.04 million, down 15.8% from FY2024.
- EBITDA carries a five-year compound annual growth rate of 51.3% (FY2020 to FY2025).
- Going back by year, EBITDA was $580.64 million in FY2024 (+100.1%), $290.16 million in FY2023 (+10.4%), $262.94 million in FY2022 (+923.2%) and $25.7 million in FY2021 (-58.4%).
- The five-year range for quarterly EBITDA is -$39.89 million (Q4 2021) to $295.45 million (Q2 2025).
- Year-over-year, EBITDA increased in four of the last six quarters, with growth averaging 86.9%.
- The fastest year-over-year change in EBITDA over five years came in Q4 2023 (growth of 372.2%), and the weakest in Q1 2023 (a decline of 46.1%).
- Business Quant data shows BMRN's EBITDA at $146.05 million (Q1 2026), -$24.17 million (Q4 2025) and -$28.21 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Biomarin Pharmaceutical | 10.64 Bn | 4.51 Bn | 786.91 Mn | 209.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 209.06 Mn |
| Mar 31, 2026 | 152.14 Mn |
| Dec 31, 2025 | -23.52 Mn |
| Sep 30, 2025 | -27.56 Mn |
| Jun 30, 2025 | 295.48 Mn |
| Mar 31, 2025 | 246.62 Mn |
| Dec 31, 2024 | 185.67 Mn |
| Sep 30, 2024 | 133.62 Mn |
| Jun 30, 2024 | 147.91 Mn |
| Mar 31, 2024 | 116.80 Mn |
| Dec 31, 2023 | 55.13 Mn |
| Sep 30, 2023 | 57.35 Mn |
| Jun 30, 2023 | 92.01 Mn |
| Mar 31, 2023 | 89.85 Mn |
| Dec 31, 2022 | 12.49 Mn |
| Sep 30, 2022 | 23.41 Mn |
| Jun 30, 2022 | 65.45 Mn |
| Mar 31, 2022 | 165.70 Mn |
| Dec 31, 2021 | -38.86 Mn |
| Sep 30, 2021 | -25.35 Mn |
API Access
Biomarin Pharmaceutical EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();